Synjardy 12.5Mg/850Mg 60TabSynjardy is a medication belonging to the class of antidiabetic drugs, containing two active substances: Empagliflozin and ...
MoreSynjardy 12.5Mg/850Mg 60TabSynjardy is a medication belonging to the class of antidiabetic drugs, containing two active substances: Empagliflozin and ...
More
Synjardy is a medication belonging to the class of antidiabetic drugs, containing two active substances: Empagliflozin and Linagliptin. This medication is used to manage blood sugar levels in patients with type 2 diabetes. It works by lowering blood glucose levels through increased insulin secretion and reduced glucose production in the liver. This product was developed by Boehringer Ingelheim and is subject to regulatory approvals from the Saudi Food and Drug Authority.
Empagliflozin and Linagliptin
Tablets, 12.5Mg/850Mg, pack containing 60 tablets
Take one tablet daily with or without food, as directed by your doctor. Do not exceed the recommended dose.
It is advised to consult a doctor before using this product during pregnancy or breastfeeding.